Viaderma Inc
ViaDerma, Inc., through its subsidiary, manufactures and sells pharmaceutical related products in the United States. The company's lead product is Vitastem, a tetracycline and topical delivery technology for antibiotics to pain relief, skincare, and other. It is also developing various products for vitiligo, psoriasis, eczema, and other skin conditions using SkinPass topical delivery system, as w… Read more
Viaderma Inc (VDRM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 6.059x
Based on the latest financial reports, Viaderma Inc (VDRM) has a cash flow conversion efficiency ratio of 6.059x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-874.84K) by net assets ($-144.40K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Viaderma Inc - Cash Flow Conversion Efficiency Trend (2008–2023)
This chart illustrates how Viaderma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Viaderma Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Viaderma Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
H&G High Conviction Ltd
AU:HCF
|
-4.118x |
|
Nusantara Inti Corpora Tbk
JK:UNIT
|
-0.084x |
|
KLONDIKE SILVER
BE:K1SN
|
-0.006x |
|
Vista Land and Lifescapes Inc
PSE:VLL
|
0.117x |
|
PLD CORPORATION
BE:P8O
|
N/A |
|
UNIVERSAL PARTNERS LTD (GBP)
SEM:UPL
|
N/A |
|
Dost Steels Ltd
KAR:DSL
|
N/A |
|
TIANJIN JINRAN -H-
BE:TL6
|
N/A |
Annual Cash Flow Conversion Efficiency for Viaderma Inc (2008–2023)
The table below shows the annual cash flow conversion efficiency of Viaderma Inc from 2008 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $123.15K | $175.00 | 0.001x | +75.68% |
| 2022-12-31 | $-1.84 Million | $-1.49K | 0.001x | +238.23% |
| 2021-12-31 | $-2.44 Million | $1.43K | -0.001x | -114.60% |
| 2020-12-31 | $-2.19 Million | $-8.77K | 0.004x | -20.56% |
| 2019-12-31 | $-3.00 Million | $-15.12K | 0.005x | -83.64% |
| 2018-12-31 | $-2.72 Million | $-83.90K | 0.031x | -80.63% |
| 2017-12-31 | $-1.05 Million | $-167.36K | 0.159x | +278.54% |
| 2016-12-31 | $-286.81K | $-12.06K | 0.042x | +108.23% |
| 2015-12-31 | $-553.90K | $-11.19K | 0.020x | -84.98% |
| 2014-12-31 | $-921.74K | $-123.94K | 0.134x | -25.46% |
| 2011-12-31 | $33.56 Million | $6.05 Million | 0.180x | -32.25% |
| 2010-12-31 | $29.21 Million | $7.78 Million | 0.266x | +88.78% |
| 2009-12-31 | $23.45 Million | $3.31 Million | 0.141x | +205.02% |
| 2008-12-31 | $-12.59K | $1.69K | -0.134x | -- |